Merck KGaA (ETR:MRK – Get Free Report)’s share price traded up 2.7% during mid-day trading on Thursday . The company traded as high as €106.40 and last traded at €106.15. 317,358 shares were traded during mid-day trading, The stock had previously closed at €103.35.
Merck KGaA Stock Performance
The company has a current ratio of 1.46, a quick ratio of 0.72 and a debt-to-equity ratio of 41.86. The firm’s fifty day moving average is €120.70 and its 200 day moving average is €117.60. The company has a market cap of $47.27 billion, a PE ratio of 17.44, a price-to-earnings-growth ratio of 2.37 and a beta of 0.72.
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.
Read More
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
